Apollo Medical Holdings Stock Return On Equity
| 3AM Stock | EUR 28.40 0.20 0.70% |
Apollo Medical Holdings fundamentals help investors to digest information that contributes to Apollo Medical's financial success or failures. It also enables traders to predict the movement of Apollo Stock. The fundamental analysis module provides a way to measure Apollo Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Apollo Medical stock.
Apollo |
Apollo Medical Holdings Company Return On Equity Analysis
Apollo Medical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Apollo Medical Holdings has a Return On Equity of 0.0. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Return On Equity (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Apollo Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Apollo Medical's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Apollo Medical could also be used in its relative valuation, which is a method of valuing Apollo Medical by comparing valuation metrics of similar companies.Apollo Medical is currently under evaluation in return on equity category among its peers.
Apollo Fundamentals
| Current Valuation | 1.28 B | |||
| Price To Book | 2.60 X | |||
| Price To Sales | 1.29 X | |||
| Revenue | 1.14 B | |||
| EBITDA | 112.08 M | |||
| Net Income | 49.05 M | |||
| Total Debt | 203.39 M | |||
| Cash Flow From Operations | 70.33 M | |||
| Number Of Employees | 15 | |||
| Market Capitalization | 197.6 M | |||
| Total Asset | 963.9 M | |||
| Z Score | 1.0 | |||
| Net Asset | 963.9 M |
About Apollo Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Apollo Medical Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Apollo Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Apollo Medical Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Apollo Stock
Apollo Medical financial ratios help investors to determine whether Apollo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Apollo with respect to the benefits of owning Apollo Medical security.